To explore the earliest proteomic changes occurring in AD, we fitted linear models comparing protein levels between A-T- (Aβ-negative, tau-negative) and A+T- (Aβ-positive, tau-negative) individuals, stratified by PET, in the TRIAD cohort. Here, MAPT is linked to Alzheimer disease.